Overview

The Gene Technology Act 2000 was enacted to provide a regulatory framework for the development, use, and release of genetically modified organisms (GMOs) in Australia, addressing the need for stringent oversight to protect human health, safety, and the environment. The Act was introduced to fill a legislative gap concerning the safe and responsible handling of GMOs, ensuring that any potential risks are identified and managed effectively. Administered by the Parliament of Australia, the policy objective of the Act is to balance the benefits of gene technology with the imperative to safeguard public health and ecological integrity. The Gene Technology Regulator, as the enforcing body, is responsible for assessing applications for activities involving GMOs and making decisions based on comprehensive risk assessments. This includes the evaluation of proposed field trials, such as the one currently under review for genetically modified wheat and barley by The University of Adelaide, which aims to enhance yield while ensuring no impact on food safety or animal feed.

Scope and Application

The scope of C2024G00062 pertains to the application for a field trial of genetically modified wheat and barley by The University of Adelaide, under the oversight of the Gene Technology Regulator. This application is specifically concerned with a project aimed at enhancing the yield of wheat and barley through genetic modification, with the proposed trial period extending from May 2024 until January 2029. The trial is limited to a single site within the jurisdiction of the Light Regional Council in South Australia, covering no more than 2 hectares annually. Notably, the genetically modified wheat and barley intended for this trial are not designated for human consumption or animal feed, thereby restricting their application to research and developmental purposes. The legislation seeks public input on the potential risks to human health and the environment, inviting submissions that reference DIR 201 and must be submitted by 12 March 2024. The Regulator's assessment and decision-making process is informed by the Risk Assessment and Risk Management Plan (RARMP) provided for this specific application, which is available for review on the Regulator's website or through direct contact.

Key Provisions

The primary sections of C2024G00062 (Gazette) pertain to the application by The University of Adelaide for a field trial of genetically modified wheat and barley (section 1). This trial, designated as DIR 201, aims to enhance yield and is proposed to occur between May 2024 and January 2029 on a single site not exceeding 2 hectares per year. The site is situated in Light Regional Council in South Australia. It is crucial to note that the genetically modified wheat and barley will not be used for human food or animal feed (section 2). The Gene Technology Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) to evaluate the potential impacts on human health and safety and the environment. The Regulator invites written submissions regarding the RARMP before making a decision on whether to issue the licence (section 3). The Act imposes several obligations on the parties involved. The University of Adelaide must adhere to the terms of the proposed trial, including the location, size, and duration specified. They are also required to follow the guidelines and risk management plans outlined in the RARMP (section 4). The Gene Technology Regulator, on the other hand, must review the application and any public submissions before deciding whether to issue the licence. They must also ensure that the trial will not pose unacceptable risks to human health and safety or the environment (section 5). Additionally, both parties must comply with any conditions set by the Regulator in the licence, if issued (section 6). Breach of the provisions of C2024G00062 (Gazette) can lead to various consequences. For individuals or entities failing to comply with the terms of the licence or the RARMP, there could be legal repercussions. These may include fines and other penalties as stipulated by the Act (section 7). The maximum penalties for non-compliance with the Act are not explicitly stated in the provided text, but they could potentially include substantial fines and even imprisonment for more severe breaches. The Regulator also has the authority to revoke a licence if it is found that the trial poses an unacceptable risk to human health or the environment (section 8). Furthermore, civil and criminal liability may apply for any harm caused by non-compliance with the Act (section 9).